CONMED Corp. Stock
CONMED Corp. Stock
We can see a decrease in the price for CONMED Corp.. Compared to yesterday it has lost -€0.600 (-1.960%).
Currently there is a rather positive sentiment for CONMED Corp. with 4 Buy predictions and 0 Sell predictions.
With a target price of 53 € there is a hugely positive potential of 76.67% for CONMED Corp. compared to the current price of 30.0 €.
Pros and Cons of CONMED Corp. in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of CONMED Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| CONMED Corp. | -1.960% | -3.774% | -21.134% | -44.865% | -12.571% | -67.447% | -72.432% |
| Bio-Rad Labs Inc. A | -0.660% | 2.341% | 5.300% | 8.094% | -6.786% | -44.455% | -50.535% |
| Haemonetics Corp. | 0.820% | -5.000% | -10.182% | - | -27.883% | - | - |
| Neogen Corp. | 1.920% | 1.258% | -16.146% | 3.205% | 30.894% | - | - |
Comments
CONMED (CNMD) was upgraded by Wall Street Zen from "buy" to "strong-buy".
Show more
Ratings data for CNMD provided by MarketBeat
CONMED (NYSE:CNMD) had its price target lowered by analysts at Piper Sandler from $68.00 to $55.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat
CONMED Corporation (NYSE: CNMD) had its price target lowered by analysts at Piper Sandler from $80.00 to $68.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat